Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01380756
What this trial is testing

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

Who this might be right for
CancerHematologic MalignanciesLeukemia+1 more
Amgen 35
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Early research (Phase 1)Study completedNCT02705989
What this trial is testing

Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 439
Early research (Phase 1)Study completedNCT04052360
What this trial is testing

Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects

Who this might be right for
Healthy Volunteers
Viatris Innovation GmbH 20
Early research (Phase 1)Study completedNCT05924243
What this trial is testing

Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

Who this might be right for
Parkinson Disease
Hoffmann-La Roche 60
Early research (Phase 1)Study completedNCT01876615
What this trial is testing

Pharmacokinetic Drug Interaction Between YH4808 and Diclofenac

Who this might be right for
Healthy
Yuhan Corporation 49
Testing effectiveness (Phase 2)Study completedNCT01230749
What this trial is testing

Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 89
Early research (Phase 1)Study completedNCT06562985
What this trial is testing

Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Who this might be right for
Acute Venous and Arterial Thrombotic and Thromboembolic EventsHealthy Volunteers
Bayer 39
Early research (Phase 1)Study completedNCT04980248
What this trial is testing

Study of ALXN1850 in Participants With Hypophosphatasia (HPP)

Who this might be right for
Hypophosphatasia
Alexion Pharmaceuticals, Inc. 15
Early research (Phase 1)WithdrawnNCT01163838
What this trial is testing

Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemia
Pfizer
Early research (Phase 1)Study completedNCT02151617
What this trial is testing

A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649

Who this might be right for
Healthy
Pfizer 40
Testing effectiveness (Phase 2)Study completedNCT06750276
What this trial is testing

Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

Who this might be right for
Liver FibrosisHepatic Cirrhosis
AstraZeneca 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05115110
What this trial is testing

Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy (SMA)
Hoffmann-La Roche 97
Early research (Phase 1)Study completedNCT04763226
What this trial is testing

Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986308 in Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 46
Early research (Phase 1)Study completedNCT06554574
What this trial is testing

Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants

Who this might be right for
Healthy
Latigo Biotherapeutics 112
Early research (Phase 1)Study completedNCT01870297
What this trial is testing

LY3025876 in Participants With Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 72
Testing effectiveness (Phase 2)Study completedNCT05747924
What this trial is testing

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 90
Early research (Phase 1)Looking for participantsNCT06455280
What this trial is testing

SIPLIZUMAB in AILD and LT Patients

Who this might be right for
Autoimmune Liver DiseaseLiver Transplant DisorderAutoimmune Hepatitis+3 more
Elizabeth C. Verna 8
Testing effectiveness (Phase 2)Study completedNCT02014558
What this trial is testing

Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 265
Early research (Phase 1)Study completedNCT05960708
What this trial is testing

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

Who this might be right for
Allergic DiseaseChronic Spontaneous UrticariaChronic Inducible Urticaria+1 more
Yuhan Corporation 30
Next Page